BRD2 and neoplasm: In agreement with previous reports of the cytotoxicity of the proteasome inhibitors bortezomib and MG132 in vitro[19,34], we observed that treatment with these drugs, as single agents, induced concentration-dependent decreases in the survival of clonogens from two tumour cell lines - SK-N-BE(2c) and UVW/NAT.